Beverly S. Mitchell
Impact in
- Physiology top 0.1%
- Adenosine and Purinergic Signaling
- Transplantation top 1%
Papers in
-
- Biochemical and Molecular Research 65
- RNA modifications and cancer 12
- Epidemiology 38
- Cytomegalovirus and herpesvirus research 36
- Co-authors
- Józef Spychała (13 shared papers)Kiran Mahajan (3 shared papers)Sally A. Hunsucker (3 shared papers)Donna S. Shewach (7 shared papers)Craig B. Thompson (4 shared papers)Jennifer S. Dayton (7 shared papers)Jing Gu (7 shared papers)Albert Zimmermann (7 shared papers)
- Journals
- Blood (12 papers)Journal of Biological Chemistry (9 papers)Advances in experimental medicine and biology (8 papers)Journal of Clinical Investigation (7 papers)Journal of Clinical Oncology (7 papers)
- Partner nations
- United StatesGermanyIndia
In The Last Decade
Beverly S. Mitchell
117 papers receiving 5.5k citations
Beverly S. Mitchell's Hit Papers
Peers
Comparison fields: 5 of 124
- Physiology 948
- Transplantation 246
- Hematology 1.0k
- Genetics 715
- Molecular Biology 3.6k
Countries citing papers authored by Beverly S. Mitchell
This map shows the geographic impact of Beverly S. Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beverly S. Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beverly S. Mitchell more than expected).
Fields of papers citing papers by Beverly S. Mitchell
This network shows the impact of papers produced by Beverly S. Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beverly S. Mitchell. The network helps show where Beverly S. Mitchell may publish in the future.
Co-authors
The 25 scholars most cited alongside Beverly S. Mitchell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 125 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase I Trial of the Proteasome Inhibitor PS-341 in Patients With Refractory Hematologic Malignancies Hit paper breakdown → | 2002 | 586 |
| 2 | 2002 | 237 | |
| 3 | 2005 | 219 | |
| 4 | 2007 | 199 | |
| 5 | 1991 | 142 | |
| 6 | 2005 | 129 | |
| 7 | 1991 | 117 | |
| 8 | 1981 | 117 | |
| 9 | 1995 | 103 | |
| 10 | 1992 | 102 | |
| 11 | Resistance to 1-beta-D-arabinofuranosylcytosine in human T-lymphoblasts mediated by mutations within the deoxycytidine kinase gene. | 1992 | 100 |
| 12 | 2005 | 98 | |
| 13 | 2004 | 97 | |
| 14 | 2003 | 95 | |
| 15 | 1980 | 94 | |
| 16 | 2001 | 93 | |
| 17 | 1998 | 93 | |
| 18 | 1996 | 91 | |
| 19 | 1992 | 86 | |
| 20 | 1994 | 86 |
About Beverly S. Mitchell
Beverly S. Mitchell is a scholar working on Molecular Biology, Epidemiology, Physiology, Hematology and Public Health, Environmental and Occupational Health, having authored 125 papers that have together received 5.7k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (65 papers), Adenosine and Purinergic Signaling (37 papers), Cytomegalovirus and herpesvirus research (36 papers), Acute Lymphoblastic Leukemia research (19 papers), Acute Myeloid Leukemia Research (17 papers), HIV/AIDS drug development and treatment (16 papers), RNA modifications and cancer (12 papers) and Chronic Lymphocytic Leukemia Research (10 papers). The work is most often cited by research in Physiology (948 citations), Transplantation (246 citations), Hematology (1.0k citations), Genetics (715 citations) and Molecular Biology (3.6k citations). Beverly S. Mitchell has collaborated with scholars based in United States, Germany and India. Frequent co-authors include Józef Spychała, Kiran Mahajan, Sally A. Hunsucker, Donna S. Shewach, Craig B. Thompson, Jennifer S. Dayton, Jing Gu, Albert Zimmermann, Laurence A. Turka and Dale A. Ramsden. Their work appears in journals such as Blood, Journal of Biological Chemistry, Advances in experimental medicine and biology, Journal of Clinical Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.